The Kerala High Court ruled the government may intervene when patented medicines are prohibitively priced, directing the Centre to gather nationwide data on the affordability of life-saving drugs. The case concerned breast cancer treatments abemaciclib and ribociclib, patented by Eli Lilly and Novartis. The court said Section 100 of the Patents Act could be invoked, but left the decision to the government.
Kerala HC Backs Government Action on Pricy Patented Drugs
Source: Economic Times